Palliative chemotherapy in carcinoma nasopharynx

by Vijay M Patil, Amit Joshi, Vanita Noronha, Vikas Talreja, Vijai Simha, Sachin Dhumal, Bhavesh Bandekar, Arun Chandrasekharan, Kumar Prabhash
Published 2019-01-01

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

by Vanita Noronha, Vijay M Patil, Amit Joshi, Atanu Bhattacharjee, Davinder Paul, Sachin Dhumal, Shashikant Juvekar, Supreeta Arya, Kumar Prabhash
Published 2017-01-01

Once-a-week versus once-every-3-weeks cisplatin in patients receiving chemoradiation for locally advanced head-and-neck cancer: A survey of practice in India

by Gautam Goyal, Vijay M Patil, Vanita Noronha, Amit Joshi, Satvik Khaddar, Sajak Kakkar, Ritesh Pruthy, Purvish Parikh, Kumar Prabhash
Published 2018-01-01

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer

by Vanita Noronha, Nikhil Pande, Amit Joshi, Vijay Patil, Vaishakhi Trivedi, Anuradha Chougule, Amit Janu, Abhishek Mahajan, Vikas Talreja, Kumar Prabhash
Published 2020-01-01

Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysis

by Vivek Agarwala, Anant Ramaswamy, Amit Joshi, Vijay Maruti Patil, Vanita Noronha, Santosh Menon, B Palak Popat, Nilesh Sable, Kumar Prabhash
Published 2018-01-01

Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with solid neoplasms: A real-world experience from a tertiary cancer center

by Akhil Kapoor, Vanita Noronha, Vijay M Patil, Amit Joshi, Nandini Menon, George Abraham, Vikas Talreja, Hollis D′Souza, Kumar Prabhash
Published 2019-01-01

Twin trouble

by Akhil Rajendra, Vanita Noronha, Bhausaheb Bagal, Devayani Madhav Niyogi, Tanuja Manjanath Shet, Nilendu Chandrakant Purandare, Anil Ramakant Tibdewal, Kumar Prabhash
Published 2020-01-01

Aprepitant for patients with head-and-neck cancer receiving once-a-week cisplatin with radiation: Is it required?

by Vanita Noronha, Hollis D'souza, Amit Kumar Choudhary, Vijay M Patil, Gunjesh Kumar Singh, Amit Joshi, Nandini Menon, Kumar Prabhash
Published 2021-01-01

Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1–5 sites of oligometastatic non-small cell lung cancer: a study proto...

by Sadhna Kannan, Kumar Prabhash, Anil Tibdewal, Naveen Mummudi, Vanita Noronha, Vijay Patil, Nilendu Purandare, Amit Janu, Jai Prakash Agarwal, Shashank Srinivasan
Published 2021-03-01

ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patients

by Anand Patil, Bharati Shriyan, Parsshava Mehta, Mrudula Patil, Murari Gurjar, Manjunath Nookala, Vijay Patil, Amit Joshi, Vanita Noronha, Kumar Prabhash, Vikram Gota
Published 2021-07-01

Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.

by Anuradha Chougule, Kumar Prabhash, Vanita Noronha, Amit Joshi, Abhishek Thavamani, Pratik Chandrani, Pawan Upadhyay, Sagarika Utture, Saral Desai, Nirmala Jambhekar, Amit Dutt
Published 2013-01-01

EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.

by Vanita Noronha, Kumar Prabhash, Abhishek Thavamani, Anuradha Chougule, Nilendu Purandare, Amit Joshi, Rashmi Sharma, Saral Desai, Nirmala Jambekar, Amit Dutt, Rita Mulherkar
Published 2013-01-01

Chemoradiation in Unresectable Oral Cavity Cancer: A Myth or Reality!

by Vijay Maruti Patil, Vanita Noronha, Amit Joshi, Amit Kumar, Hollis Dsouza, Atanu Bhattacharjee, Abhishek Mahajan, Nilesh Sabale, Sarbani Ghosh-Laskar, Kumar Prabhash
Published 2020-10-01

Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis

by Vanita Noronha, Vijay M. Patil, Gunjesh Kumar Singh, Amit Joshi, Nandini Menon, Sarbani Ghosh Lashkar, Vijayalakshmi Mathrudev, Kavita Nawale Satam, Kumar Prabhash
Published 2021-05-01

Polypharmacy and potentially inappropriate medication use in older Indian patients with cancer: A prospective observational study

by Vanita Noronha, Anant Ramaswamy, Shreya Chandrashekhar Gattani, Renita Castelino, Manjunath Nookala Krishnamurthy, Nandini Menon, Vijay M Patil, Vikram S Gota, Shripad Banavali, Kumar Prabhash
Published 2021-01-01

Molecular tumor board: Case 1-Interplay of EGFR, MET and PD-L1 in non-small cell lung carcinoma

by Akhil Kapoor, Vanita Noronha, Anuradha Chougule, Vijay M Patil, Nandini Menon, Amit Joshi, Pratik Chandrani, Rajiv Kumar, Vikas Talreja, Hollis D′Souza, Kumar Prabhash
Published 2019-01-01

Hypothyroidism post-chemoradiation on outcomes in head-and-neck cancer

by Vijay M Patil, Vanita Noronha, Amit Joshi, Tanmoy Kumar Mandal, Atanu Bhattacharjee, Alok Goel, Vikas Talreja, Arun Chandrasekharan, Nikhil Pande, Anant Ramaswamy, Kumar Prabhash
Published 2018-01-01

Authors' reply to Batra et al., Chadha et al., and Deb et al.

by Akhil Kapoor, Vanita Noronha, Anuradha Chougule, Vijay M Patil, Nandini Menon, Amit Joshi, Pratik Chandrani, Rajiv Kumar, Vikas Talreja, Hollis D'Souza, Kumar Prabhash
Published 2020-01-01

Molecular tumor board: Case 4 Salivary Gland Cancer: Novel therapeutic options as a result of comprehensive molecular profiling

by Akhil Kapoor, Vanita Noronha, Anuradha Chougule, Pratik Chandrani, Omshree Shetty, Vijay M Patil, Amit Joshi, Nandini Menon, Munita Bal, Richa Vaish, Amit Kumar, Kumar Prabhash
Published 2020-01-01

Molecular tumor board: Case 2 – Evolution of resistance in anaplastic lymphoma kinase driven non-small-cell lung carcinoma

by Akhil Kapoor, Vanita Noronha, Omshree Shetty, Anuradha Chougule, Pratik Chandrani, Vijay M Patil, Nandini Menon, Amit Joshi, Rajiv Kumar, Mamta Gurav, Amit Kumar, Kumar Prabhash
Published 2020-01-01